[E1662-1vn] 17. Biofunctional Chemistry, Biotechnology

[E1662-1vn-03] Development of prodrug nanoparticles with highly selective drug release in cancer cells

^○Aki Shibata¹, Yoshitaka Koseki¹, Keita Tanita¹, Ryuju Suzuki¹, Anh T.N. Dao^1,2, Hitoshi Kasai¹ (1. IMRAM, Tohoku University, 2. Nagasaki University)

[Lang.] English

Keywords:drug delivery system, anticancer agent, tertiary hydroxy group, prodrug, nanoparticle